Bioglan AB is a pharmaceutical company based in Malmö that specializes in the development and manufacturing of semi-solid and liquid pharmaceuticals. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive product development services alongside full-scale manufacturing capabilities. Bioglan AB emphasizes quality assurance throughout its production processes, ensuring that its diverse range of pharmaceutical products meets industry standards.
In addition to its manufacturing and development services, Bioglan AB is actively involved in international collaborations and projects. The company has been noted in recent news for its engagement with sales permits for medicines, reflecting its role in the regulatory aspects of the pharmaceutical industry. Bioglan AB is committed to innovation, supporting various therapeutic areas and addressing market needs through its ongoing research and development efforts.